PRICE T ROWE ASSOCIATES INC /MD/ - IMPAX LABORATORIES INC ownership

IMPAX LABORATORIES INC's ticker is IPXL and the CUSIP is 45256B101. A total of 165 filers reported holding IMPAX LABORATORIES INC in Q4 2013. The put-call ratio across all filers is 0.63 and the average weighting 0.1%.

Quarter-by-quarter ownership
PRICE T ROWE ASSOCIATES INC /MD/ ownership history of IMPAX LABORATORIES INC
ValueSharesWeighting
Q1 2018$481,000
+17.3%
24,747
+0.6%
0.00%
Q4 2017$410,000
-17.8%
24,6040.0%0.00%
Q3 2017$499,000
-5.8%
24,604
-25.2%
0.00%
Q2 2017$530,000
+13.2%
32,904
-11.2%
0.00%
Q1 2017$468,000
+45.3%
37,034
+52.6%
0.00%
Q4 2016$322,000
-43.0%
24,270
+1.8%
0.00%
Q3 2016$565,000
-2.2%
23,850
+19.0%
0.00%
Q2 2016$578,000
-10.0%
20,0400.0%0.00%
Q1 2016$642,000
-23.3%
20,040
+2.3%
0.00%
Q4 2015$837,000
+32.9%
19,580
+9.4%
0.00%
Q3 2015$630,000
-23.4%
17,9000.0%0.00%
Q2 2015$822,000
+9.6%
17,900
+11.9%
0.00%
Q1 2015$750,000
+29.3%
16,000
-12.6%
0.00%
Q4 2014$580,000
+33.6%
18,3000.0%0.00%
Q3 2014$434,000
-20.9%
18,3000.0%0.00%
Q2 2014$549,000
+13.7%
18,3000.0%0.00%
Q1 2014$483,000
-33.8%
18,300
-36.9%
0.00%
Q4 2013$730,000
+102.2%
29,000
+64.8%
0.00%
Q3 2013$361,000
-48.6%
17,600
-50.0%
0.00%
Q2 2013$702,00035,2000.00%
Other shareholders
IMPAX LABORATORIES INC shareholders Q4 2013
NameSharesValueWeighting ↓
Orbimed Advisors 5,415,600$162,414,0001.91%
Broadfin Capital, LLC 1,217,858$36,524,0001.80%
NEW AMSTERDAM PARTNERS LLC/NY 695,100$20,846,0001.36%
Healthcare Value Capital, LLC 50,000$1,500,0001.26%
Iguana Healthcare Management, LLC 75,000$2,249,0001.05%
Matarin Capital Management, LLC 78,292$2,347,977,0001.04%
Independence Capital Asset Partners, LLC 253,089$7,590,0001.04%
Tekla Capital Management LLC 344,683$10,337,0000.95%
Penn Capital Management Company, LLC 794,641$23,831,0000.92%
Leonard Capital Management, Inc. 87,661$2,629,0000.89%
View complete list of IMPAX LABORATORIES INC shareholders